Phase II Trial of LBH589 (Panobinostat) in Adult Patients With Recurrent Malignant Gliomas.
Phase of Trial: Phase II
Latest Information Update: 15 Jul 2010
At a glance
- Drugs Panobinostat (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 15 Jul 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 23 Feb 2009 New trial record